• 제목/요약/키워드: technetium 99m

검색결과 122건 처리시간 0.023초

Lymphatic Delivery of $^{99m}Tc$-labeled Dextran Acetate Particles Including Cyclosporine A

  • Kim, Jin;Chung, Kyong-Hwan;Lee, Chang-Moon;Seo, Young-Soon;Song, Ho-Chun;Lee, Ki-Young
    • Journal of Microbiology and Biotechnology
    • /
    • 제18권9호
    • /
    • pp.1599-1605
    • /
    • 2008
  • Biodistribution and lymphoscintigraphy of cyclosporine A (CyA) and technetium-99m ($^{99m}Tc$) were studied using ${^99m}Tc$-labeled dextran acetate (DxA) including CyA. DxA particles were prepared from dextran with acetic anhydride, and CyA was loaded into them. Lymphatic delivery of ${^99m}Tc$-labeled DxA particles containing CyA was evaluated after subcutaneous injection into the foot pad of rats and compared with those of ${^99m}Tc$-labeled human serum albumin (HSA). The labeling efficiency of CyA-loaded ${^99m}Tc$-DxA particles was about 95% at 30 min. The labeling efficiency maintained stably above 80% for 12 h. The percent injected dose (%ID) of CyA-loaded ${^99m}Tc$-DxA was similar to that of ${^99m}Tc$-HSA at the inguinal lymph node after 40 min. The CyA-loaded ${^99m}Tc$-DxA could be as well distributed as ${^99m}Tc$-HSA through the lymph node. The DxA particles could steadily distribute the CyA as well as the ${^99m}Tc$ radiolabeling through the lymph node.

Development of fission 99Mo production process using HANARO

  • Lee, Seung-Kon;Lee, Suseung;Kang, Myunggoo;Woo, Kyungseok;Yang, Seong Woo;Lee, Junsig
    • Nuclear Engineering and Technology
    • /
    • 제52권7호
    • /
    • pp.1517-1523
    • /
    • 2020
  • The widely used medical isotope technetium-99 m (99mTc) is a daughter of Molybdenum-99 (99Mo), which is mainly produced using dedicated research reactors from the nuclear fission of uranium-235 (235U). 99mTc has been used for several decades, which covers about 80% of the all the nuclear diagnostics procedures. Recently, the instability of the supply has become an important topic throughout the international radioisotope communities. The aging of major 99Mo production reactors has also caused frequent shutdowns. It has triggered movements to establish new research reactors for 99Mo production, as well as the development of various 99Mo production technologies. In this context, a new research reactor project was launched in 2012 in Korea. At the same time, the development of fission-based 99Mo production process was initiated by Korea Atomic Energy Research Institute (KAERI) in 2012 in order to be implemented by the new research reactor. The KAERI process is based on the caustic dissolution of plate-type LEU (low enriched uranium) dispersion targets, followed by the separation and purification using a series of columns. The development of proper waste treatment technologies for the gaseous, liquid, and solid radioactive wastes also took place. The first stage of this process development was completed in 2018. In this paper, the results of the hot test production of fission 99Mo using HANARO, KAERI's 30 MW research reactor, was described.

$^{99m}Tc$ Pertechnetate를 사용(使用)한 뇌(腦)스캐닝 (Technetium 99m Pertechnetate Brain Scanning)

  • 이상민;박진영;이안기;정주일;홍창기;이종헌;고창순
    • 대한핵의학회지
    • /
    • 제2권1호
    • /
    • pp.59-66
    • /
    • 1968
  • Technetium 99m pertechnetate brain scanning were performed in 3 cases of head injury (2 chronic subdural hematomas and 1 acute epidural hematoma), 2 cases of brain abscess and I case of intracerebral hematoma associated with arteriovenous anomaly. In all the cases brain scintigrams showed "hot areas." Literatures on radioisotope scanning of intracranial lesions were briefly reviewed. With the improvement of radioisotope scanner and development of new radiopharmaceuticals brain scanning became a safe and useful screening test for diagnosis of intracranial lesions. Brain scanning can be easily performed even to a moribund patient without any discomfort and risk to the patient which are associated with cerebral angiography or pneumoencephalography. Brain scanning has been useful in diagnosis of brain tumor, brain abscess, subdural hematoma, and cerebral vascular diseases. In 80 to 90% of brain tumors positive scintigrams can be expected. Early studies were done with $^{203}Hg$-Neohydrin or $^{131}I$-serum albumin. With these agents, however, patients receive rather much radiation to the whole body and kidneys. In 1965 Harper introduced $^{99m}Tc$ to reduce radiation dose to the patient and improve statistical variation in isotope scanning.

  • PDF

Development of Industrial-Scale Fission 99Mo Production Process Using Low Enriched Uranium Target

  • Lee, Seung-Kon;Beyer, Gerd J.;Lee, Jun Sig
    • Nuclear Engineering and Technology
    • /
    • 제48권3호
    • /
    • pp.613-623
    • /
    • 2016
  • Molybdenum-99 ($^{99}Mo$) is the most important isotope because its daughter isotope, technetium-99m ($^{99m}Tc$), has been the most widely used medical radioisotope for more than 50 years, accounting for > 80% of total nuclear diagnostics worldwide. In this review, radiochemical routes for the production of $^{99}Mo$, and the aspects for selecting a suitable process strategy are discussed from the historical viewpoint of $^{99}Mo$ technology developments. Most of the industrial-scale $^{99}Mo$ processes have been based on the fission of $^{235}U$. Recently, important issues have been raised for the conversion of fission $^{99}Mo$ targets from highly enriched uranium to low enriched uranium (LEU). The development of new LEU targets with higher density was requested to compensate for the loss of $^{99}Mo$ yield, caused by a significant reduction of $^{235}U$ enrichment, from the conversion. As the dramatic increment of intermediate level liquid waste is also expected from the conversion, an effective strategy to reduce the waste generation from the fission $^{99}Mo$ production is required. The mitigation of radioxenon emission from medical radioisotope production facilities is discussed in relation with the monitoring of nuclear explosions and comprehensive nuclear test ban. Lastly, the $^{99}Mo$ production process paired with the Korea Atomic Energy Research Institute's own LEU target is proposed as one of the most suitable processes for the LEU target.

Transcolonic scintigraphy for diagnosis of canine portosystemic shunts

  • Lee, Young-won
    • 대한수의학회지
    • /
    • 제39권2호
    • /
    • pp.390-393
    • /
    • 1999
  • Transcolonic scintigraphy using $^{99m}Technetium$ pertechnetate ($^{99m}TcO_{4}$) was performed in 5 dogs with portosystemic shunts. In all dogs, the activity in the heart was seen before liver activity. Also time activity curve was revered. The mean shunt index in 5 dogs was 82.3% (range 79.6~87.1%). Transcolonic scintigraphy is quick, simple and useful diagnostic method for canine portosysternic shunts.

  • PDF

Investigation of transport of radionuclide in a thermal stratification test facility using radiotracer technique

  • Pant, Harish Jagat;Goswami, Sunil;Chafle, Sunil B.;Sharma, Vijay Kumar;Kotak, Vimal;Shukla, Vikram;Mishra, Amitanshu;Gohel, Nilesh C.;Bhattacharya, Sujay
    • Nuclear Engineering and Technology
    • /
    • 제54권4호
    • /
    • pp.1449-1455
    • /
    • 2022
  • A radiotracer investigation was carried out in a Thermal Stratification Test Facility (TSTF) with objectives of investigating the dispersion and diffusion of radionuclide and effectiveness of the thermocline to minimize the radionuclide content in the hot water layer. Technetium-99m (99mTc) as sodium pertechnetate was used as a radiotracer in the investigation. Qualitative analysis showed that a thermocline is formed within the TSTF and is effective in preventing the transport of radionuclide from bottom section to the top section of the facility. It was found that the radiotracer injected at the bottom of the pool took about 17.4 h to disperse from bottom to the top of the facility. The results of the investigation helped in understanding the effectiveness of hot water layer and thus to minimize the pool top radiation levels.